RAC

4.64%

$1.85 race oncology ltd

[INTERVIEW] Breaking Barriers in Cancer Treatment: Race Oncology Pioneers a New Era with Bisantrene, page-215

First 215 Last

Share
Profile

Follow
ttppxx

115 Posts.

73

20/05/24

22:17

Post #: 73923299
Share

Originally posted by ralom: ↑

I enjoy reading your detailed posts
Apologies if this has been asked before but do you have any affiliation with RAC or the Ceo ?
Apart from being a shareholder

Expand

Now 2 years old, but still relevant IMO!

Originally posted by Mason14: ↑

All good and thanks. I am just your everyday shareholder.

Tillett asked if he could use some of the tables I created in a company prospectus a while ago - I believe he changed them a little. I was happy to share them, didn't receive anything for them, and would have humbly declined if I was offered anything for them. Just happy to feel as though I had helped.

I am clearly very active in this space and have a drive for understanding this company, so Daniel has answered many questions from me regarding Bisantrene and declined to answer MANY more, haha.

The natural next question might be why I publish material online. I sacrificed a lot for my Masters with the main things being time and money. Much like my current devotion to the game of golf and achieving scratch within 5-years, I have come to think of RAC as a long-term Masters project that is self-paced. There is short-term sacrifice for long-term benefit. I publish material online because it forces me to understand the data at a depth required to explain it in as simple terms as possible to a wide audience. Teaching something helps me solidify my own learning, streamlining my thinking to focus on exactly what matters which will continue to grow over time alongside more learnings from this journey.

Expand

Great work Mason. I am ready for an update!

RAC Price at posting: $1.49 Sentiment: Buy Disclosure: Held
27 Upvote

0 Great analysis

Reply

Top Stories

Talking the US election, the spectre of Trump and what's hot on the ASX200: Wealth Within

WC8

Leia pegmatite pulls up recoveries of 84% lithium for Wildcat in WA

AI stocks: What to expect in 2024-25

IVR

Investigator Resources hits 8m @ 1.06% copper on-site Stuart Shelf JV project acreage

BYH

Bryah gains $408K government rebate for work on copper target Narracoota

There are more pages in this discussion • 20 more messages in this thread...

First 215 Last

Add RAC (ASX) to my watchlist

(20min delay)
Last $1.85		Change -0.090(4.64%)		Mkt cap ! $315.1M

Open	High	Low	Value	Volume
$1.93	$1.97	$1.85	$314.6K	164.1K

Buyers (Bids)

No.	Vol.	Price($)
1	44	$1.85

Sellers (Offers)

Price($)	Vol.	No.
$1.89	500	1

View Market Depth

No.	Vol.	Price($)
1	44	1.850
2	8804	1.840
3	6774	1.830
1	100	1.820
6	12943	1.800

Price($)	Vol.	No.
1.890	500	1
1.910	2941	1
1.940	148	1
1.950	1000	1
1.975	2000	1

Last trade - 16.10pm 16/07/2024 (20 minute delay)

RAC (ASX) Chart

[INTERVIEW] Breaking Barriers in Cancer Treatment: Race Oncology Pioneers a New Era with Bisantrene, page-215

Talking the US election, the spectre of Trump and what's hot on the ASX200: Wealth Within

Leia pegmatite pulls up recoveries of 84% lithium for Wildcat in WA

AI stocks: What to expect in 2024-25

Investigator Resources hits 8m @ 1.06% copper on-site Stuart Shelf JV project acreage

Bryah gains $408K government rebate for work on copper target Narracoota

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

[INTERVIEW] Breaking Barriers in Cancer Treatment: Race Oncology Pioneers a New Era with Bisantrene, page-215

Top Stories

Talking the US election, the spectre of Trump and what's hot on the ASX200: Wealth Within

Leia pegmatite pulls up recoveries of 84% lithium for Wildcat in WA

AI stocks: What to expect in 2024-25

Investigator Resources hits 8m @ 1.06% copper on-site Stuart Shelf JV project acreage

Bryah gains $408K government rebate for work on copper target Narracoota

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News